Global Stable Isotope Labeled Compounds Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Stable Isotope Labeled Compounds Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Stable isotopically labeled compounds are non-radioactive chemical substances where one or more element within a compound has been substituted for its stable isotope. Common stable isotopes used in research include 2H (Deuterium or D), 13C, 15N and 18O.

Market Overview:

The latest research study on the global Stable Isotope Labeled Compounds market finds that the global Stable Isotope Labeled Compounds market reached a value of USD 272.07 million in 2022. It’s expected that the market will achieve USD 346.45 million by 2028, exhibiting a CAGR of 4.11% during the forecast period.

Medical isotopes have continued to be produced during the COVID-19 pandemic, but hospitals have experienced shortages due to bottlenecks in transportation and distribution, according to the International Atomic Energy Agency (IAEA) survey on research reactors producing isotopes.

The IAEA survey showed that most producers continued to produce medical isotopes during the lockdown, and the government has designated these production facilities as essential equipment. Most of the research reactors producing isotopes continue to operate after meeting IAEA safety standards and taking measures to prevent the impact and spread of the coronavirus, including reducing on-site personnel and maintaining social distancing.

But downstream in the supply chain, as well as transportation, have been significantly negatively impacted. The product is usually produced and shipped by air to all over the world. During the global epidemic, many air routes no longer operate, and the borders of many countries are also closed. This seriously hinders the flow of the supply chain. In addition, the head of the IAEA's isotope products and radiation technology department said that since most of the research and teaching activities that require the use of isotopes have been suspended, many hospitals have also delayed diagnostic applications, and the agency is evaluating the current medical isotope needs. The downstream demand market in the supply chain has been hit due to COVID-19.

R&D Sector Dominates Stable Isotope Labeled Compounds Market

Part of the growth in the stable isotope labeled compounds industry is attributable to an increase in R&D spending. Both governments and major players are investing in product development. Stable isotope tracers can safely be used simultaneously on the same subject without compromising future research. The plasma volume required to analyze isotopic enrichment from one sample is small enough to study even preterm infants. Extensive studies on the biological side effects and metabolic fate of this compound are currently underway. In addition to applications in metabolomic research, stable isotope-labeled compounds find applications in medical diagnostic research, proteomics, and environmental analysis. Mass spectrometry and nuclear magnetic resonance can be used to identify isotopes on molecules. Factors such as increasing R&D in the biopharmaceutical and medical industries and investments in proteomics research are expected to drive the growth of the stable isotope labeled compounds market.

Restrictions on Stable Isotope Labeled Compounds

There are some limitations of stable isotope labeled compounds hindering the growth of the market. One of the main disadvantages of stable isotopes is the cost of producing labeled compounds and the expensive equipment required for analysis, which until recently was a labor-intensive process. This limits the production of stable isotope-labeled compounds and their applications, thus further limiting the market.

Region Overview:

In global comparison, a significant portion of the revenue was generated in United States (36.23% in 2022).

Company Overview:

Merck KGaA is one of the major players operating in the Stable Isotope Labeled Compounds market, holding a share of 14.01% in 2022.

Merck KGaA

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis and infertility; and develops liquid crystal mixtures, organic light-emitting diode (OLED) materials, cosmetic active ingredients, pigments for coatings, and high-tech materials. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems. The company serves healthcare, performance materials, and life sciences markets.

Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. (CIL) is the worlds leading producer of stable isotopes and stable isotope-labeled compounds. CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (nonradioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. CILs products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide.

Segmentation Overview:

As for product types, the Deuterium segment held the largest market share in 2022.

Application Overview:

The market's largest segment by application is the segment Clinical Diagnostics, with a market share of 47.52% in 2022.

Research

Stable isotope-labeled compounds have been synthesized and used by scientists in various fields of biomedical research, such as drug metabolism and toxicology, proteomics, etc.

Clinical Diagnostics

Stable isotope labeled compounds can be used for clinical diagnosis, such as 13 C urea breath test.

Industrial

Stable isotope-labeled compounds can be used in the nuclear industry, such as the application of 3-He in superconducting electromagnetic cooling.

Key Companies in the global Stable Isotope Labeled Compounds market covered in Chapter 3:

Medical Isotopes, Inc.
Merck KGaA
Omicron Biochemicals, Inc.
LGC (CDN Isotope)
Taiyo Nippon Sanso Corporation
SimSon Pharma
Mesbah Energy Co.
MPD Chemicals (IsoSciences)
VIVAN Life Sciences
Shimadzu (Alsachim)
Huayi Isotopes Co
PerkinElmer Inc.
13c Molecular Inc
URENCO Limited
CortecNet
Cambridge Isotope Laboratories, Inc.
BOC Sciences

In Chapter 4 and Chapter 14.2, on the basis of types, the Stable Isotope Labeled Compounds market from 2018 to 2029 is primarily split into:

Deuterium
Carbon-13
Oxygen-18
Nitrogen-15
6Li and 7Li
28Si, 29Si, and 30Si
Germanium-73
Chlorine-35 and chlorine-37
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Stable Isotope Labeled Compounds market from 2018 to 2029 covers:

Research
Clinical Diagnostics
Industrial
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)